Marilyn Kay Glassberg Csete MD, FACP, FCCP

Dr. Marilyn Glassberg, M.D., professor of medicine, surgery, and pediatrics at the University of Miami Miller School of Medicine, is a leading expert in rare lung diseases. After completing her undergraduate studies at Wellesley College and initial research training with Drs. Judah Folkman and Bruce Zetter at Harvard Medical School, she completed her medical degree and postgraduate training at the University of Miami Miller School of Medicine and University of Miami Affiliated Hospitals.

Dr. Glassberg runs a basic science research lab in collaboration with Dr. Sharon Elliot, professor of surgery, where they have completed and published seminal studies on the mechanisms of cell-based therapy in fibrotic lung diseases. Dr. Glassberg recently completed the first study of intravenously delivered bone marrow-derived mesenchymal stem cells in patients with idiopathic pulmonary fibrosis (IPF). She has recently received approval from the FDA to conduct ReCell, the first multi-dose randomized, double-blind trial of intravenously delivered mesenchymal stem cells in patients with IPF.